Clinical trial
Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms
NCT00179556 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- September 30, 2005
- Enrollment
- 210
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
menopausal symptoms